NPCE
NeuroPace Inc
NASDAQ · Healthcare · Medical - Devices · US
$12.30
−5.46%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 3.64x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 35.53x
- Price / sales
- 4.27x
- Price / cash flow
- -37.56x
Enterprise value
- Enterprise value
- $440.4M
- EV / sales
- 4.46x
- EV / EBITDA
- -38.55x
- EV / EBIT
- -29.21x
- Market cap
- $422.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026